These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2871646)

  • 21. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.
    Ruiz P; Kolbeck PC; Scroggs MW; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):91-5. PubMed ID: 3276070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
    Nankivell BJ; Hibbins M; Chapman JR
    Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface adenosine deaminase (ADA) and its complexing protein (ADCP) in human T-lymphoid cells.
    Dinjens WN; van der Boon J; ten Kate J; Zeijlemaker WP; De Bruijn CH; Bosman FT; Khan PM
    Adv Exp Med Biol; 1986; 195 Pt B():407-14. PubMed ID: 3532703
    [No Abstract]   [Full Text] [Related]  

  • 29. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
    te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
    Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry M; Ferguson RM
    Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The detection of renal allograft rejection by fine-needle intrarenal manometry.
    Wilson RG; Taylor RM; Proud G
    Br J Surg; 1985 Oct; 72(10):816-8. PubMed ID: 3899243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin-A nephrotoxicity and acute cellular rejection in renal transplant recipients: correlation between radionuclide and histologic findings.
    Kim EE; Pjura G; Lowry P; Verani R; Sandler C; Flechner S; Kahan B
    Radiology; 1986 May; 159(2):443-6. PubMed ID: 3515421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical graft evolution of lymphocytes, polymorphonuclear cells, and antigen expression in tubular renal cells in the urine sediment of 20 renal allograft recipients.
    Péfaur J; Triviño R; Navarrete C; Oberhauser E; Melys M; Morales I; Salinas P; Mocarquer A
    Transplant Proc; 2003 Nov; 35(7):2500-5. PubMed ID: 14611996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection.
    Brown FG; Nikolic-Paterson DJ; Chadban SJ; Dowling J; Jose M; Metz CN; Bucala R; Atkins RC
    Transplantation; 2001 Jun; 71(12):1777-83. PubMed ID: 11455258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection.
    Chareandee C; Herman WH; Hricik DE; Simonson MS
    Am J Kidney Dis; 2000 Sep; 36(3):541-9. PubMed ID: 10977786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.